Partner Collie James was quoted in a Corporate Counsel article discussing how state attorneys general are taking action against fake or illegal versions of popular weight-loss and diabetes drugs, highlighting how states are stepping in to address safety concerns, false advertising, and misuse by some clinics and pharmacies amid a perceived void in federal enforcement.
“The current administration’s focus on reducing the size and power of a variety of federal agencies is likely to have a significant impact on the level of enforcement by those agencies, and is likely to provide further opportunity for active AGs,” Collie said. “The current effort to curb counterfeit GLP-1 medications provides a ready example of this development.”
Read the full Corporate Counsel article >>
Subscription may be required.